AzTrials
AzTrials

Spinal Cord InjuryFESNCT02602639

Functional Electrical Stimulation With Rowing as Exercise After Spinal Cord Injury

A study testing Functional electrical stimulation rowing (Odstock 4 channel neuromuscular stimulator with Concept 2 Rower) in people with Spinal Cord Injury and Paraplegia, run by University of Manitoba at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Currently, those with spinal cord injury (SCI) demonstrate increased prevalence of obesity (75%) cardiovascular disease (30 - 50%), type II diabetes (21%) and osteoporosis in the legs (100%) when compared to the general population. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Spinal Cord Injury, Paraplegia, Tetraplegia
What is being tested?
Functional electrical stimulation rowing (Odstock 4 channel neuromuscular stimulator with Concept 2 Rower)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteCanada
Study dates
Oct 2015to Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Have a spinal cord injury, C5-T12 (level), AIS A-D (severity)
  • Be aged 18-75 for duration of study
  • Medically stable and healthy enough to complete exercise requirements
  • Willing and able to complete the at-home training requirements as prescribed
  • Willing and able to complete the exercise sessions as prescribed
  • Willing and able to complete the VO2 testing throughout the study
  • Willing and able to complete the DEXA (Dual-energy X-ray absorptiometry) scans during the study
  • Able to understand and follow written or verbal instructions from study staff

Who cannot join

  • Current pressure ulcer(s) at sites of electrical stimulation
  • Previous spontaneous or low-impact leg fracture
  • Previous diagnosis of cardiovascular disease (ie enlarged heart, heart murmur)
  • Unsatisfactory results of EKG (electrocardiogram) screening test
  • Known thyroid dysfunction
  • Kidney disease
Show all 15Show fewer
  • Cancer
  • Blood pressure > 140/90 mmHg
  • Currently taking blood pressure medication
  • History of epilepsy
  • Current hand, arm or shoulder injury
  • Current deep vein thrombosis
  • Implanted electronic cardiac device (pace maker, defibrillator, etc)
  • Ventilator-dependent
  • Unable to follow written and verbal instructions

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Manitoba

    Winnipeg, Manitoba

Other trials in Canada

About this study

Official title: Development of a Spinal Cord Injury-specific Exercise-based Capacity

Currently, those with spinal cord injury (SCI) demonstrate increased prevalence of obesity (75%) cardiovascular disease (30 - 50%), type II diabetes (21%) and osteoporosis in the legs (100%) when compared to the general population. It is important to identify the modes and intensities of exercise most likely to generate a reduction in these inactivity-related diseases in this population.

Therefore, the main purpose of this pilot research project is to implement and test a form of a spinal cord injury-specific exercise, known as FES rowing (FES: functional electrical stimulation).

Being tested
Functional electrical stimulation rowing (Odstock 4 channel neuromuscular stimulator with Concept 2 Rower)
Medical subject headings
Spinal Cord Injuries, Paraplegia, Quadriplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Functional electrical stimulation rowing (Odstock 4 channel neuromuscular stimulator with Concept 2 Rower)Device

    Participants will strengthen their quadriceps and hamstrings using electrical stimulation for up to 12 weeks (using an Odstock 4 channel neuromuscular stimulator). Then participants will use a seated rower (Concept 2 Rower, fitted with a backrest that allows those with spinal cord injury to engage in rowing) in conjunction with the electrical stimulation for 12-24 weeks.

Study groups in NCT02602639
Study groupRoleWhat they receive
Functional electrical stimulation rowingExperimentalUsing an Odstock 4 channel neuromuscular stimulator with Concept 2 Rower
Receives: Device: Functional electrical stimulation rowing (Odstock 4 channel neuromuscular stimulator with Concept 2 Rower)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak VO2 (volume oxygen) output during exercise

    Peak VO2 testing will be performed before beginning rower training and again at the end of the 24 weeks of training. Testing will be performed with an arm ergometer, rowing without electrical stimulation, and rowing with electrical stimulation. This will assess energy use, time to fatigue, and perceived exertion.

    Measured: 24 weeks compared to baseline

Secondary outcomes (2)
  1. Body composition

    Participants will have their body composition (specifically leg percent fat and muscle, and bone mineral density) measured before beginning training and at the end of the 24 weeks of training.

    Measured: 24 weeks compared to baseline

  2. Leg EMG (electromyogram) while rowing

    Participants will perform the rowing exercise while having EMG of multiple leg muscles.

    Measured: Throughout study (up to 36 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Nov 2015 (estimated)
  2. Study startOct 2015
  3. Primary completionDec 2021 (estimated)
  4. Study completionSep 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
6 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02602639
Sponsor's protocol ID
H2014:174
Acronym
FES
Status last verified
Jun 2020
First submitted
5 Nov 2015
Last updated
26 Jun 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Functional electrical stimulation rowing (Odstock 4 channel neuromuscular stimulator with Concept 2 Rower) in people with Spinal Cord Injury and Paraplegia, run by University of Manitoba at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak VO2 (volume oxygen) output during exercise (time frame: 24 weeks compared to baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
FES Clinical Trial NCT02602639 | AzTrials